Patents by Inventor Veronique Crocq-Stuerga

Veronique Crocq-Stuerga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the preparation of a compound useful as an inhibitor of TAFIa
    Patent number: 8865906
    Abstract: The present invention relates to a process for the preparation of a compound of the formula I, which comprises reacting a compound of the formula IV with an oxalic acid diester and to novel intermediate compounds used therein.
    Type: Grant
    Filed: May 11, 2010
    Date of Patent: October 21, 2014
    Assignee: Sanofi
    Inventors: Kai Rossen, Volker Kraft, Hermut Wehlan, Antony Bigot, Veronique Crocq-Stuerga
  • PROCESS FOR THE PREPARATION OF A COMPOUND USEFUL AS AN INHIBITOR OF TAFIA
    Publication number: 20120245358
    Abstract: The present invention relates to a process for the preparation of a compound of the formula I, which comprises reacting a compound of the formula IV with an oxalic acid diester and to novel intermediate compounds used therein.
    Type: Application
    Filed: May 11, 2010
    Publication date: September 27, 2012
    Applicant: SANOFI
    Inventors: Kai Rossen, Volker Kraft, Hermut Wehlan, Antony Bigot, Veronique Crocq-Stuerga
  • NOVEL PROCESS FOR THE PREPARATION OF CHIRAL COMPOUNDS DERIVED FROM HEXANOIC ACID ESTERS AND INTERMEDIATES USED IN THE SYNTHESIS OF CHIRAL-2-(BROMOMETHYL)-2-ETHYLHEXANOIC ACID
    Publication number: 20100160670
    Abstract: The present invention comprises a novel process for the preparation of a chiral compound of formula (I) wherein R1 is hydroxyl or a group which activates the carboxyl and R2 is alkyl optionally substituted by halogen or benzyl, its preparation, its application in the synthesis of chiral 2-bromomethyl-2-ethylhexanoic acid and novel intermediates.
    Type: Application
    Filed: March 4, 2010
    Publication date: June 24, 2010
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Veronique Crocq-Stuerga, Patrick Roussel
  • Product, method and intermediates for the preparation of azetidine derivatives
    Patent number: 7687493
    Abstract: The present invention relates to a novel method for the preparation of azetidine derivatives such as N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-quinol-6-ylmethylsulfonamide and the dihydrochloride thereof and N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5-difluorophenyl)methylsulfonamide.
    Type: Grant
    Filed: March 22, 2007
    Date of Patent: March 30, 2010
    Assignee: Aventis Pharma SA
    Inventors: Stephane Mutti, Michel Lavigne, Luc Grondard, Joel Malpart, Joerg Rieke-Zapp, Veronique Crocq-Stuerga
  • NOVEL PROCESS FOR THE PREPARATION OF CHIRAL COMPOUNDS DERIVED FROM HEXANOIC ACID ESTERS AND INTERMEDIATES USED IN THE SYNTHESIS OF CHIRAL 2-(BROMOMETHYL)-2-ETHYLHEXANOIC ACID
    Publication number: 20090163737
    Abstract: The present invention comprises a novel process for the preparation of a chiral compound of formula (I) wherein R1 is hydroxyl or a group which activates the carboxyl and R2 is alkyl optionally substituted by halogen or benzyl, its preparation, its application in the synthesis of chiral 2-bromomethyl-2-ethylhexanoic acid and novel intermediates.
    Type: Application
    Filed: February 27, 2009
    Publication date: June 25, 2009
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Veronique CROCQ-STUERGA, Patrick ROUSSEL
  • NOVEL PRODUCT, METHOD AND INTERMEDIATES FOR THE PREPARATION OF AZETIDINE DERIVATIVES
    Publication number: 20070270463
    Abstract: The present invention relates to a novel method for the preparation of azetidine derivatives such as N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-quinol-6-ylmethylsulfonamide and the dihydrochloride thereof and N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5-difluorophenyl)methylsulfonamide.
    Type: Application
    Filed: March 22, 2007
    Publication date: November 22, 2007
    Applicant: SANOFI-AVENTIS
    Inventors: Stephane Mutti, Michel Lavigne, Luc Grondard, Joel Malpart, Joerg Rieke-Zapp, Veronique Crocq-Stuerga
  • Novel chiral compounds derived from hexanoic acid esters, preparation process and intermediates, use in the synthesis of chiral 2-(bromomethyl)-2-ethylhexanoic acid
    Publication number: 20040147774
    Abstract: A subject matter of the invention is a chiral compound of formula 1
    Type: Application
    Filed: December 17, 2003
    Publication date: July 29, 2004
    Applicant: Aventis Pharma S.A.
    Inventors: Veronique Crocq-Stuerga, Patrick Roussel